Abstract
Background
The extent of thyroid surgery for multifocal papillary thyroid microcarcinoma (PTMC) remains controversial. Studies on the optimal surgical approach for a multifocal PTMC are scarce. This study aimed to compare the effectiveness of thyroidectomy and lobectomy for the treatment of multifocal PTMC.
Methods
A population-based retrospective cohort of patients with multifocal PTMC was analyzed using the Surveillance, Epidemiology, and End Results (SEER) database between 2004 and 2017, and divided into two groups (thyroidectomy, lobectomy) based on the surgical approach. The clinicopathologic features and survival outcomes were compared between the two groups. Cox proportional hazards regression analysis to explore prognostic factors of survival. Propensity score matching (PSM) was used to balance covariates.
Results
Overall, a total of 9387 multifocal PTMC patients were included in the study. Among them, 8,107 (86.36%) patients received thyroidectomy, and 1280 (13.64%) patients underwent lobectomy. Compared to patients in the thyroidectomy group, patients in the lobectomy group were diagnosed with older age (50.47 years vs. 49.32 years, p = 0.003), a higher proportion of males (20.47% vs. 14.99%, p < 0.001), larger tumors (6.22 mm vs. 4.97 mm, p < 0.001), and more frequently underwent radiotherapy (35.40% vs. 10.16%, p < 0.001). Multivariate Cox regression analysis revealed that age was the only independent prognostic factor for thyroid cancer-specific survival (TCSS), and the determinants of overall survival (OS) were age and gender. Unadjusted survival analysis revealed no difference between the two treatment groups in TCSS (p = 0.598) and OS (p = 0.126). After 1:1 Propensity Score Matching (PSM), there was still no difference in TCSS (p = 0.368) or OS (p = 0.388). The stratified analysis revealed that for patients aged under or above 55, thyroidectomy was not associated with superior BCSS or OS (p > 0.05).
Conclusions
Thyroidectomy was not associated with improved survival compared to thyroid lobectomy for patients with multifocal PTMC.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03794-4/MediaObjects/12020_2024_3794_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03794-4/MediaObjects/12020_2024_3794_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03794-4/MediaObjects/12020_2024_3794_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03794-4/MediaObjects/12020_2024_3794_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12020-024-03794-4/MediaObjects/12020_2024_3794_Fig5_HTML.png)
Similar content being viewed by others
Data availability
The SEER data set used in this publication is owned by the National Cancer Institute. Interested party can apply for access from the National Cancer Institute (https://seer.cancer.gov/data/access.html). The data analysed in the current study are available from the corresponding author on reasonable request.
References
R.L. Siegel, K.D. Miller, N.S. Wagle, A. Jemal, Cancer statistics, 2023. CA Cancer J. Clin. 73(1), 17–48 (2023)
U.C. Megwalu, P.K. Moon, Thyroid cancer incidence and mortality trends in the United States: 2000-2018. Thyroid 32(5), 560–570 (2022)
C. Hedinger, E.D. Williams, L.H. Sobin, The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63(5), 908–911 (1989)
B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1), 1–133 (2016)
D. Giordano, P. Gradoni, G. Oretti, E. Molina, T. Ferri, Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin. Otolaryngol. 35(2), 118–124 (2010)
Z. Al-Qurayshi, N. Nilubol, R.P. Tufano, E. Kandil, Wolf in sheep’s clothing: Papillary thyroid microcarcinoma in the US. J. Am. Coll. Surg. 230(4), 484–491 (2020)
Y. Wang, Q. Guan, J. Xiang, Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients. Int. J. Surg 55, 98–102 (2018)
S. Xue, P. Wang, Z.A. Hurst, Y.S. Chang, G. Chen, Active surveillance for papillary thyroid microcarcinoma: Challenges and prospects. Front. Endocrinol. 9, 736 (2018)
Y. Ito, A. Miyauchi, Active surveillance may be the best initial management for papillary thyroid microcarcinoma. J. Endocrine Soc. 7(7), bvad063 (2023)
T. Yan, W. Qiu, J. Song, T. Ying, Y. Fan, Z. Yang, Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis. Clin. Endocrinol. 95(1), 209–216 (2021)
X. Wu, B.L. Li, C.J. Zheng, X.D. He, Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma. World J. Clin. Cases 8(8), 1350–1360 (2020)
Y.K. So, M.W. Kim, Y.I. Son, Multifocality and bilaterality of papillary thyroid microcarcinoma. Clin. Exp. Otorhinolaryngol. 8(2), 174–178 (2015)
J.W. Feng, H. Pan, L. Wang, J. Ye, Y. Jiang, Z. Qu, Determine the optimal extent of thyroidectomy and lymphadenectomy for patients with papillary thyroid microcarcinoma. Front. Endocrinol. 10, 363 (2019)
Y.W. Jeon, H.G. Gwak, S.T. Lim, J. Schneider, Y.J. Suh, Long-term prognosis of unilateral and multifocal papillary thyroid microcarcinoma after unilateral lobectomy versus total thyroidectomy. Ann. Surg. Oncol. 26(9), 2952–2958 (2019)
B.C. James, L. Timsina, R. Graham, P. Angelos, D.A. Haggstrom, Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years. Surgery 166(1), 41–47 (2019)
A.W. Wu, M.B. Wang, C.T. Nguyen, Surgical practice patterns in the treatment of papillary thyroid microcarcinoma. Arch. Otolaryngology-head Neck Surg. 136(12), 1182–1190 (2010)
K.W. Park, A.Y. Han, C.M. Kim, M.B. Wang, C.T. Nguyen, Is lobectomy sufficient for multifocal papillary thyroid microcarcinoma? Am. J. Otolaryngol. 44(4), 103881 (2023)
M.A. Adam, J. Pura, P. Goffredo et al. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J. Clin. Endocrinol. Metab. 100(1), 115–121 (2015)
F. Dong, L. Zhou, S. Wang, J. Mao, C. Liu, W. Shi, Clinical characteristics-assisted risk stratification for extent of thyroidectomy in patients with 1-4 cm solitary intrathyroidal differentiated thyroid cancer. Front. Endocrinol. 12, 790730 (2021)
B. Yang, G. Niu, X. Li, F. Ma, Y. Ma, S. Hu, Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old. Front. Endocrinol. 13, 1015319 (2022)
Q. Liu, B. Ma, M. Song, W. Sun, H. Zhang, Age-dependent changes in the prognostic advantage of papillary thyroid cancer in women: A SEER-based study. Clin. Endocrinol. 99, 342–349 (2023)
Y.H. Lee, Y.M. Lee, T.Y. Sung et al. Is male gender a prognostic factor for papillary thyroid microcarcinoma? Ann. Surg. Oncol. 24(7), 1958–1964 (2017)
V. Harries, L.Y. Wang, M. McGill et al. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? Surgery 167(1), 10–17 (2020)
I.D. Hay, M.E. Hutchinson, T. Gonzalez-Losada et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144(6), 980–987 (2008).
W. Zheng, J. Li, P. Lv, Z. Chen, P. Fan, Treatment efficacy between total thyroidectomy and lobectomy for patients with papillary thyroid microcarcinoma: A systemic review and meta-analysis. Eur. J. Surg. Oncol. 44(11), 1679–1684 (2018)
J.W. Feng, Z. Qu, A.C. Qin, H. Pan, J. Ye, Y. Jiang, Significance of multifocality in papillary thyroid carcinoma. Eur. J. Surg. Oncol. 46(10 Pt A), 1820–1828 (2020)
H.S. Kazaure, S.A. Roman, J.A. Sosa, The impact of age on thyroid cancer staging. Cur. Opin. Endocrinol. Diabetes Obesity 25(5), 330–334 (2018)
Author information
Authors and Affiliations
Contributions
X.A. designed the study, performed further data analysis, and drafted the manuscript. K.Z. and Y.X. interpreted the data and assisted in writing. L.L. and L.X. assisted in writing and revising the manuscript. J.L. and P.S. performed data extraction and initial analysis. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics
This study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments. This retrospective study was reviewed and approved by the Ethics Committee of The General Hospital of Western Theater Command. For this type of study informed consent is not required. No human participants or human tissue involved in this study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ai, X., Zhang, K., Xu, J. et al. The survival after thyroidectomy versus lobectomy in multifocal papillary thyroid microcarcinoma patients. Endocrine (2024). https://doi.org/10.1007/s12020-024-03794-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12020-024-03794-4